Status:
TERMINATED
Uncontrolled Hypertension Management (TEAM-HTN)
Lead Sponsor:
Madigan Army Medical Center
Collaborating Sponsors:
Telemedicine & Advanced Technology Research Center
Analytics4Medicine, LLC
Conditions:
Uncontrolled Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Current guideline directed medical therapies (GDMT) for hypertension (HTN) endorse a trial and error approach based on drug class. This pilot study will evaluate the efficacy of a Clinical Decision Su...
Detailed Description
Current guideline directed medical therapies (GDMT) for hypertension (HTN) endorse a trial and error approach based on drug class. This pilot study will evaluate the efficacy of a Clinical Decision Su...
Eligibility Criteria
Inclusion
- Providers with prescriptive authority practicing in outpatient clinics at a military treatment facility in the Northwest.
- Patients 18 years or older with uncontrolled hypertension receiving care in an outpatient setting that can give a valid consent (over age 18 years, the ability to read and understand English, and cognitively intact). Active duty service members who will not be deployed or due to change duty station for the duration of the study.
- \-
Exclusion
- 1\. Credentialed providers without prescribing privileges in good standing. 2. Age less than 18 years, night shift workers, anyone who cannot give a valid informed consent, pregnant or breast feeding women, prisoners, patients on renal dialysis, transplant recipients, life expectancy less than 1 year, and those disqualified during screening procedures.
- \-
Key Trial Info
Start Date :
January 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03281772
Start Date
January 24 2017
End Date
July 31 2018
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madigan Army Medical Center
Tacoma, Washington, United States, 98431-1100